Nuclear receptor LXR as a novel therapeutic antitumoral target in glioblastoma

Antonio Moschetta

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Nuclear receptor LXR as a novel therapeutic antitumoral target in glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences